Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus

被引：0
|
作者：
A K Hemanth Kumar
V Chandrasekaran
T Kannan
A Lakshmi Murali
J Lavanya
V Sudha
Soumya Swaminathan
Geetha Ramachandran
机构：
[1] National Institute for Research in Tuberculosis,Department of Biochemistry and Clinical Pharmacology
[2] State TB Officer,undefined
[3] District TB Officer,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Tuberculosis; Anti-tuberculosis drug concentrations; Revised National Tuberculosis Control Programme; Diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 70
页数：5
相关论文
共 50 条
  • [1] Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus
    Kumar, A. K. Hemanth
    Chandrasekaran, V.
    Kannan, T.
    Murali, A. Lakshmi
    Lavanya, J.
    Sudha, V.
    Swaminathan, Soumya
    Ramachandran, Geetha
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (01) : 65 - 70
  • [2] Anti-tuberculosis drug concentrations and treatment outcomes in patients with both tuberculosis and HIV infection
    Baniasadi, Shadi
    Tabarsi, Payam
    Nadji, Seyed Alireza
    Kobarfard, Farzad
    Eskandari, Raha
    Fahimi, Fanak
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus
    Lyu, Mengyuan
    Wang, Dongmei
    Zhao, Junwei
    Yang, Zengwei
    Chong, Weelic
    Zhao, Zhenzhen
    Ming, Liang
    Ying, Binwu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 : 69 - 77
  • [4] Clincal interpretation of the anti-tuberculosis drug concentrations in diabetic and non-diabetic tuberculosis patients
    Jacob, Nilan T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (08) : 1049 - 1049
  • [5] Anti-tuberculosis drug concentrations and treatment outcomes among HIV-infected patients with tuberculosis
    Baniasadi, Shadi
    Alehashem, Maryam
    Kobarfard, Farzad
    Tabarsi, Payam
    HIV & AIDS REVIEW, 2018, 17 (02): : 111 - 116
  • [6] Clincal interpretation of the anti-tuberculosis drug concentrations in diabetic and non-diabetic tuberculosis patients
    Nilan T Jacob
    European Journal of Clinical Pharmacology, 2017, 73 : 1049 - 1049
  • [7] Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India
    Swaminathan, S
    Paramasivan, CN
    Ponnuraja, C
    Iliayas, S
    Rajasekaran, S
    Narayanan, RR
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (08) : 896 - 900
  • [8] Aspirin enhances the clinical efficacy of anti-tuberculosis therapy in pulmonary tuberculosis in patients with type 2 diabetes mellitus
    Wang, Wenjie
    Du, Zhixiang
    Ni, Mingyue
    Wang, Zijian
    Liang, Manman
    Sheng, Haoyu
    Zhang, Aiping
    Yang, Jianghua
    INFECTIOUS DISEASES, 2020, 52 (10) : 721 - 729
  • [9] Serum Concentrations Of Anti-Tuberculosis Drugs And Outcome Of Tuberculosis Treatment
    Park, J.
    Song, J. -H.
    Lee, Y.
    Cho, Y.
    Yoon, H. -I.
    Lee, C. -T.
    Lee, J. -H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [10] Evaluation of Systemic Inflammation Before and After Standard Anti-tuberculosis Treatment in Patients With Active Pulmonary Tuberculosis and Diabetes Mellitus
    Lopez-Gonzalez, Jesus Andres
    Martinez-Soto, Juan Manuel
    Avila-Cervantes, Carolina
    Mata-Pineda, Ana Lourdes
    Alvarez-Hernandez, Gerardo
    Alvarez-Meza, Jehan Bonizu
    Bolado-Martinez, Enrique
    Candia-Plata, Maria del Carmen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
12345